$3,600,000 of PFIZER INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R. 4101 - Cancer Drug Parity Act of 2025 H.R. 5178 - Sickle Cell Disease Comprehensive Care Act S. 3510 - Biosimilar Inspection Modernization Act of 2025 Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Codification FDA-2026-N-4699 - Expedited Investigational New Drug (IND) pilot program Section 301 Investigation re: Germany Issues FDA User Fee Agreements: 2027 PDUFA Cycle 340B Program Reform Prior Authorization Vaccine Access and Coverage FDA Modernization and Reforms Drug Pricing PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage Pandemic and All-Hazards Preparedness Act (PAHPA) H.R. 5256 - 340B ACCESS Act H.R. 9599 - SECURE 340B Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Vaccine Access and Coverage 340B Program Reform Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule/Essential Medicines PBM Reform Drug Pricing Medicare/Medicaid Issues H.R. 9102 - Biotech Investment National Security Act (BINSA) Act: US Competitiveness, Biotechnology Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients FDA-2026-N-4699 - Expedited Investigational New Drug (IND) pilot program International Supply Chain Section 301 Investigation re: Germany Issues Foreign Freeriding Issues Non-Tariff Trade Barriers Global Health Competitiveness Issues Clinical Trial Issues"
You can find more data on corporate lobbying on Quiver Quantitative.
PFE Congressional Stock Trading
Members of Congress have traded $PFE stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:
- SENATOR TOMMY TUBERVILLE sold up to $50,000 on 06/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
PFE Insider Trading Activity
PFE insiders have traded $PFE stock on the open market 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $PFE stock by insiders over the last 6 months:
- ALBERT BOURLA (Chairman & CEO) purchased 38,000 shares for an estimated $1,000,920
- RONALD E BLAYLOCK purchased 39,231 shares for an estimated $998,821
- MORTIMER J BUCKLEY purchased 37,632 shares for an estimated $960,368
- JENNIFER B. DAMICO (SVP & Controller) has made 0 purchases and 2 sales selling 5,278 shares for an estimated $134,661.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
PFE Hedge Fund Activity
We have seen 1,314 institutional investors add shares of PFE stock to their portfolio, and 1,411 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 52,548,228 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,265,361,330
- BLACKROCK, INC. added 31,412,883 shares (+6.3%) to their portfolio in Q2 2026, for an estimated $756,422,222
- JPMORGAN CHASE & CO added 23,010,244 shares (+inf%) to their portfolio in Q2 2026, for an estimated $554,086,675
- WELLINGTON MANAGEMENT GROUP LLP removed 22,090,883 shares (-44.3%) from their portfolio in Q2 2026, for an estimated $531,948,462
- PACER ADVISORS, INC. added 16,793,903 shares (+inf%) to their portfolio in Q2 2026, for an estimated $404,397,184
- MARSHALL WACE, LLP removed 15,280,392 shares (-95.0%) from their portfolio in Q2 2026, for an estimated $367,951,839
- NORGES BANK removed 12,027,991 shares (-16.4%) from their portfolio in Q2 2026, for an estimated $289,634,023
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
PFE Price Targets
Multiple analysts have issued price targets for $PFE recently. We have seen 5 analysts offer price targets for $PFE in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Chris Schott from JP Morgan set a target price of $28.0 on 07/08/2026
- Rajesh Kumar from HSBC set a target price of $28.0 on 07/06/2026
- Carter Gould from Cantor Fitzgerald set a target price of $27.0 on 07/06/2026
- Trung Huynh from RBC Capital set a target price of $25.0 on 06/10/2026
- Geoff Meacham from Citigroup set a target price of $27.0 on 04/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
